The review by kwun and knechtle-"can it B?"-asks whether b cells are responsible for chronic rejection of transplants

Transplantation

Volumn 88, Issue 8, 2009, Pages 978-979

  Terasaki, Paul I ^a  

^a TERASAKI FOUNDATION LABORATORY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BORTEZOMIB; HLA ANTIBODY; IMMUNOGLOBULIN; RITUXIMAB;

ACUTE GRAFT REJECTION; B LYMPHOCYTE; CELLULAR IMMUNITY; CHRONIC GRAFT REJECTION; GLOMERULOPATHY; GRAFT SURVIVAL; INCIDENCE; NOTE; PATHOGENESIS; PLASMA CELL; PLASMAPHERESIS; PRIORITY JOURNAL; T LYMPHOCYTE;

B-LYMPHOCYTES; CHRONIC DISEASE; GRAFT REJECTION; HLA ANTIGENS; HUMANS; LEUKOCYTES; MULTICENTER STUDIES AS TOPIC; TRANSPLANTATION IMMUNOLOGY;

EID: 70350442411     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/TP.0b013e3181b998fd     Document Type: Note

References (10)

1. Doll R, Hill AB. The mortality of doctors in relation to smoking habits; a preliminary report. BMJ 1954; 4877: 1451.
2. Hill AB. The environment and disease: association or causation?Proc R Soc Med 1965; 58: 295.
3. Terasaki PI, Cai J. Human leukocyte antigen antibodies and chronic rejection: From association to causation. Transplantation 2008; 86: 2008.
4. Terasaki PI, Ozawa M, Castro R. Four-year follow-up of a prospective trialof HLA and MICA antibodiesonkidney graft survival.Am JTrans-plant 2007; 7: 408.
5. Feucht HE, Lederer SR, Kluth B.Humoral alloreactivity in recipients of renal allografts as a risk factor for the development of delayed graft function. Transplantation 1998; 65: 757.
6. Gloor JM, Sethi S, Stegall MD, et al. Transplant glomerulopathy: Sub-clinical incidence and association with alloantibody. Am J Transplant 2007; 7: 2124.
7. Smith RN, Kawai T, Boskovic S, et al. Four stages and lack of stable accommodation in chronic alloantibody-mediated renal allograft rejection in Cynomolgus monkeys. Am J Transplant 2008; 8: 1662.
8. Terasaki P, Lachmann N, Cai J. Summary of the effect of de novo HLA antibodies on chronic kidney graft failure. Clin Transpl 2006:455.
9. Everly MJ, Everly JJ, Susskind B, et al. Bortezomib provides effective therapy for antibody-and cell-mediated acute rejection. Transplantation 2008; 86: 1754.
10. Trivedi HL, Terasaki PI, Feroz A, et al. Abrogation of anti-HLA antibodies via proteasome inhibition. Transplantaion 2009;87:1555.